Venetoclax in Combination With ASTX727

Venetoclax in Combination With ASTX727, an All-ORal Therapy for Chronic Myelomonocytic Leukemia and Other MDS/MPN With Excess Blasts (VICTORY-MDS/MPN): A Randomized, Phase 2 Trial

Near Add Your Location

Center of Excellence

UVA Cancer Center
University of Virginia Health System
Charlottesville, VA
  • Accepting patients

Center of Excellence

Robert H. Lurie Comprehensive Cancer Center
Northwestern University Feinberg School of Medicine
Chicago, IL
  • Accepting patients

Center of Excellence

  • Accepting patients
  • Accepting patients
Chao Family Comprehensive Cancer Center
University of California, Irvine
Orange, CA
  • Accepting patients

Center of Excellence

  • Accepting patients
495 hidden based on your filters. Show All

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.